I do not think an article in the NEJM will move the MSB share price significantly. The share price is pretty much what everyone is fixated on. An FDA roadmap will be the Remedy.
I thought it a little unusual when Fred G. (chief med. officer) Waded In and said we are in for a "Nexus". Lets hope he doesn't lose a gumboot.
I have suggested week 49/50 for this Nexus after which MSB shares under A$2.00 will be a distant memory IMO.
The pointy end is approaching!
Keep Calm & Have a Cuppa.
What.
I do not think an article in the NEJM will move the MSB share...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.020(1.95%) |
Mkt cap ! $1.164B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | $1.00 | $2.641M | 2.584M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 528197 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 6444 | 4 |
View Market Depth
| Last trade - 11.40am 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |